Simply Wall St.
Galectin Therapeutics Inc.'s (NASDAQ:GALT) top owners are retail investors with 55% stake, while 20% is held by insiders
📊
AI Sentiment
Positive
6/10
Galectin Therapeutics Inc. News
Latest updates and market news for GALT
1 news
Jan 17 - Jan 23, 2026
Page 1
Share this news page